Ovarian dysgerminoma: a therapeutic challenge.
Dysgerminoma remains a rare but quite interesting tumor. Over the last 40 years, the prognosis has markedly improved with a 5 year survival increasing from around 30% to more than 80%. Precise diagnosis and adequate staging are mandatory to define the best treatment approach aiming to cure the woman, while preserving her quality of life (ovarian function and fertility).
Danhier
S
S
Department of Radiotherapy, Institut Jules Bordet, Brussels, Belgium.
Van Houtte
P
P
D000293:Adolescent; D000328:Adult; D003131:Combined Modality Therapy; D003952:Diagnostic Imaging; D004407:Dysgerminoma / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*